In Metastatic Breast Cancer, Primary Resections on the Decline
Surgical resection rates of the primary tumor in metastatic breast cancer has declined in recent years, possibly reflecting changes in practice after trails showed no survival benefit.
Stay updated with breaking news from Presection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Surgical resection rates of the primary tumor in metastatic breast cancer has declined in recent years, possibly reflecting changes in practice after trails showed no survival benefit.
Proposed surveillance intervals and strategies are necessary following endoscopic submucosal dissection of dysplasia and early gastrointestinal cancer considered pathologically curative.
The expanded approval is for the adjuvant treatment of advanced melanoma after complete resection in patients aged 12 years and older.
Osimertinib will be available within the Cancer Drugs Fund for patients with EGFR exon 19 deletions or exon 21 substitution mutations.
Endoscopic resection of T1 esophageal adenocarcinoma is associated with excellent overall survival, yet long-term surveillance is still required for possible recurrence.